Results 211 to 220 of about 1,901,604 (311)

Bacterial Pigments as Potential Antitumor Agents Against Gastrointestinal Cancers: A Comprehensive Systematic Review

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Gastrointestinal cancers (GICs) constitute one of the leading causes of cancer‐related morbidity and mortality worldwide. Despite currently available therapeutic strategies, new approaches and procedures are needed for their prevention and treatment.
Raúl Vergara, Ricardo F. S. Pereira, Carla C. C. R. de Carvalho, Jose Prados, Consolación Melguizo, Raul Ortiz   +5 more
wiley   +1 more source

To the Editor: Disarmament in the Medical Student Research Arms Race: Counting What Matters. [PDF]

J Grad Med Educ
Tumin D.
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Prevalence of perinatal depression in Ethiopia: An umbrella review of systematic review and meta-analysis studies. [PDF]

PLoS One
Necho M, Shegaw M, Anbesaw T, Birru N, Ayano G, Tsehay M, Getnet W, Yimer S, Belete A, Zenebe Y, Birhan Z, Tiruneh C.   +11 more
europepmc   +1 more source

MEDLINE, pubmed, and pubmed central ^®: Analogous or dissimilar

Journal of Indian Society of Pedodontics and Preventive Dentistry, 2016
openaire   +3 more sources

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Correction: Securing Federated Learning With Blockchain in the Medical Field: Systematic Literature Review. [PDF]

J Med Internet Res
Wang X, Xie Y, Chen X, Yang J, Li R, Gao W, Yan Z, Zhou H, Ye Z.   +8 more
europepmc   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Worldwide research trends on the <i>Helicobacter pylori</i>-gut microbiome nexus: a bibliometric analysis. [PDF]

Front Immunol
Li L, Cai F, Liu S, Peng P, Liang J, Liu Z, Xu H, Mo W, Qin J, Tang S, Ruan H, Zhang J, Liang C, Liu S, Qin M, Qin R, Luo F, Xiong G, Yang C, Geng Y, Zou J, Huang J.   +21 more
europepmc   +1 more source

Effect of developmental changes on pharmacokinetics of drugs used in the treatment of infant acute lymphoblastic leukaemia—A comprehensive review

British Journal of Clinical Pharmacology, EarlyView.
While the event‐free survival (EFS) of children treated for acute lymphoblastic leukaemia (ALL) has improved greatly in the last decades, the EFS for patients diagnosed with ALL before the age of one is still under 50%. This outcome further decreases when infants have a rearrangement in the gene encoding histone‐lysine N‐methyltransferase 2A (KMT2A ...
Tirsa de Kluis, Leiah J. Brigitha, Lidwien M. Hanff, Alwin D. R. Huitema, Inge M. van der Sluis, Meta H. M. Diekstra   +5 more
wiley   +1 more source